BioTrinity 2009, April 2-3

Now in its 3rd year, OBN’s BioTrinity 2009 conference unites the UK’s life science industry. Come and experience what will be the best biotech partnering and investment conference in the country through this two-day programme. Join top-notch industry executives, including the South East region’s most innovative biotech entrepreneurs, major pharmaceutical companies, life science research leaders, policy makers and internationally prominent investors at the biotechnology event of the year: BioTrinity 2009.

NEW for 2009:

50+ VCs and investors partnering and Invitation–only Investor Dinner
Licensing delegates from 65% of the top 20 global pharma
Biotech Community Gala Dinner and Golf Tournament
Investment/corporate presentations by biotech and medtech companies
Private partnering rooms and booths
Significantly expanded networking space

Facts from 2008

500+ one-to-one partnering meetings
2000 meeting requests
400+ delegates
270 companies
12 countries represented

BioTrinity 2009 welcomes senior licensing professionals at global pharma companies including Genzyme, Merck, Shire, GSK, Roche, Novartis, Bristol Myers-Squibb, Eli Lilly, Takeda, and Teva among others.

BioTrinity 2009 has welcomed confirmations from more investment firms than ever including Abingworth, Atlas, Avlar, MVM, Excalibur, and corporate venturers SR One, Novo A/S, TRI Inc, MPHVM, and Genzyme Ventures, among the 25 already confirmed. Over 50 investment firms are expected to confirm by April 1. See which other companies are participating.

Who should attend?

Biotech Executives

8 minute presentation opportunity to pharma and investor audience
Panel discussions for emerging biotechs, finance and key issues
Private 1-to-1 partnering rooms and booths

Mid & Large Pharma Executives

Access to Company presentations (Biotechnology and Life Sciences)
Private 1-to-1 partnering rooms and booths
Opportunity for dedicated partnering rooms

Investors

Invitation-only investor dinner
Wide range of investment opportunities
Private 1-to-1 partnering rooms
Opportunity for dedicated partnering rooms

Testimonials (read more testimonials):

"...As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship"
Gordon J Woodrow, VP Business Development, Proteros biostructures

"...I would like to congratulate you on an excellent meeting."
Tim Haines, Partner, Abingworth Management

"...Congratulations on such a good event … I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me."
Dr Charles Potter, CEO, Glide Pharma

"...the conference was a great success. There was a high calibre of participants and the event has raised the profile the Oxford and Thames Valley biotech cluster. This will create a rising tide for us all."
David Mott, Investment Director, Oxford Capital Partners

"I found the feedback from presenting at the OBN meeting truly excellent. I not only had a lot of questions after the presentation but it generated press interest and many follow up meetings in the following days. This is testament to the quality of the attendees at the meeting"
David Phillips, SVP, Sales and Marketing, BioFocus DPI (Galapagos)

Building value in a bioscience company isn’t easy. Raising your company’s profile and establishing high-quality partners in finance, licensing and business development takes time and effort. But now there’s a proven fast-track approach: BioTrinity 2009, the premier biotech business partnering and investment conference in the UK .

As the annual showcase event for the regional bioscience super-cluster, BioTrinity 2009 Oxford brings together decision-makers from biotech and pharma together with expert professional advisers and VC finance representatives. And with its proven “gold standard” online industry partnering service, delegates can pre-book up to 36 one-to-one meetings over two days in private rooms.

There’s no doubt that the BioTrinity format works. Last year over 500 partnering meetings brought together more than 400 delegates from nearly 300 companies to discuss over 100 licensing opportunities. And this year the event promises to be even bigger: we have doubled partnering capacity to meet the expected demand. Add to that access to networking receptions, international panel discussions, company showcases and essential workshops all promises to make this the “must attend” event of the year. Can you afford to miss out?

BioTrinity is the largest biotech & medtech partnering conference in the Oxford & South East biotech region, and is unique in showcasing this super-cluster's biotech companies, which lead the UK in attracting investment.

To secure your participation in BioTrinity 2009 - Oxford , register online now:

BioTrinity is organised by OBN

Submit your email address to receive conference updates

PROJECT PARTNERS